SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-013692
Filing Date
2024-02-12
Accepted
2024-02-12 07:49:24
Documents
17
Period of Report
2024-02-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245657d1_8k.htm   iXBRL 8-K 47983
2 EXHIBIT 99.1 tm245657d1_99-1.htm EX-99.1 30358
7 GRAPHIC tm245657d1_99-1img001.jpg GRAPHIC 7180
  Complete submission text file 0001104659-24-013692.txt   369529

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abbv-20240212.xsd EX-101.SCH 5501
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20240212_def.xml EX-101.DEF 31173
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20240212_lab.xml EX-101.LAB 46033
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20240212_pre.xml EX-101.PRE 29254
19 EXTRACTED XBRL INSTANCE DOCUMENT tm245657d1_8k_htm.xml XML 14022
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 24617405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)